To coincide with the funding round, Reify launched BRIDGE (Bringing Representation, Inclusion and Diversity to Global Enrollment), an initiative that aims to identify barriers that prevent underrepresented groups from participating in trials and to develop solutions.
Apr 21, 2022 | fiercebiotech.comMacy joins the team from Reify Health where he served as director of engineering.
Jan 1, 2022 | lifepointhealth.netLast August, for example, the CRO’s parent company Reify Health raised $220 million in a series C funding round that attracted Coatue Management, ICONIQ Growth and Adams Street Partners.
Jan 1, 2022 | fiercebiotech.comBoston-based Reify Health announced a significant $220 million Series D financing led by investors such as Altimeter Capital, Coatue, Dragoneer Investment Group, ICONIQ Growth, Adams Street and Battery Ventures.
Jan 1, 2021 | biospace.comFounded in 2012, Reify Health works with an impressive client roster including half of the top-20 biopharmaceutical companies, including Eli Lilly and Amgen and has developed its platform, StudyTeam, to upgrade the systems that healthcare staff at clinical research sites depend on to run trials.
Jan 1, 2020 | hitconsultant.netAmgen has teamed up with cloud-based trial solutions firm Reify Health to help boost patients into its drug studies.
Jan 1, 2020 | fiercebiotech.com